Patient-focused inquiry on hydroxyurea therapy adherence and reasons for discontinuation in adults with sickle cell disease.

Bradford, Christopher; Miodownik, Hope; Thomas, Merin; Ogu, Ugochi O; Minniti, Caterina P

Bradford, Christopher; Miodownik, Hope; Thomas, Merin; Ogu, Ugochi O; Minniti, Caterina P.

Affiliation

Bradford C; Department of Internal Medicine, NYU Langone School of Medicine, New York, New York, USA.
Miodownik H; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Thomas M; Department of Hematology, Montefiore Medical Center, Bronx, New York, USA.
Ogu UO; Department of Medicine-Hematology, Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Minniti CP; Department of Medicine, Albert Einstein College of Medicine, New York, New York, USA.

Am J Hematol ; 97(3): E93-E95, 2022 03 01.

Article de En | MEDLINE | ID: mdl-34914130

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Adhésion au traitement médicamenteux / Hydroxy-urée / Drépanocytose Limites: Adult / Female / Humans / Male Langue: En Journal: Am J Hematol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google